Global and United States Nasal Polyps Treatment Market Report & Forecast 2023-2028

Report ID: 1788824 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Nasal Polyps Treatment Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Nasal Polyps Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Nasal Polyps Treatment Market Size for the Year 2017-2028
        1.2.2 Global Nasal Polyps Treatment Market Size for the Year 2017-2028
    1.3 Nasal Polyps Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Nasal Polyps Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Nasal Polyps Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Nasal Polyps Treatment Market Dynamics
        1.4.1 Nasal Polyps Treatment Industry Trends
        1.4.2 Nasal Polyps Treatment Market Drivers
        1.4.3 Nasal Polyps Treatment Market Challenges
        1.4.4 Nasal Polyps Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Nasal Polyps Treatment by Type
    2.1 Nasal Polyps Treatment Market Segment by Type
        2.1.1 Pharmacological Therapies
        2.1.2 Surgeries
    2.2 Global Nasal Polyps Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Nasal Polyps Treatment Market Size by Type (2017-2028)
    2.4 United States Nasal Polyps Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Nasal Polyps Treatment Market Size by Type (2017-2028)
3 Nasal Polyps Treatment by Application
    3.1 Nasal Polyps Treatment Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Ambulatory Surgical Centers
        3.1.3 Specialty Clinics
    3.2 Global Nasal Polyps Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Nasal Polyps Treatment Market Size by Application (2017-2028)
    3.4 United States Nasal Polyps Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Nasal Polyps Treatment Market Size by Application (2017-2028)
4 Global Nasal Polyps Treatment Competitor Landscape by Company
    4.1 Global Nasal Polyps Treatment Market Size by Company
        4.1.1 Top Global Nasal Polyps Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Nasal Polyps Treatment Revenue by Player (2017-2022)
    4.2 Global Nasal Polyps Treatment Concentration Ratio (CR)
        4.2.1 Nasal Polyps Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Nasal Polyps Treatment in 2021
        4.2.3 Global Nasal Polyps Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Nasal Polyps Treatment Headquarters, Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Nasal Polyps Treatment Headquarters and Area Served
        4.3.2 Global Nasal Polyps Treatment Companies Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Nasal Polyps Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Nasal Polyps Treatment Market Size by Company
        4.5.1 Top Nasal Polyps Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Nasal Polyps Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Nasal Polyps Treatment Market Size by Region
    5.1 Global Nasal Polyps Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Nasal Polyps Treatment Market Size by Region (2017-2028)
        5.2.1 Global Nasal Polyps Treatment Market Size by Region: 2017-2022
        5.2.2 Global Nasal Polyps Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Nasal Polyps Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Nasal Polyps Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Nasal Polyps Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Nasal Polyps Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Nasal Polyps Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Nasal Polyps Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Nasal Polyps Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Nasal Polyps Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Nasal Polyps Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Nasal Polyps Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 OptiNose US
        7.1.1 OptiNose US Company Details
        7.1.2 OptiNose US Business Overview
        7.1.3 OptiNose US Nasal Polyps Treatment Introduction
        7.1.4 OptiNose US Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.1.5 OptiNose US Recent Development
    7.2 Regeneron Pharmaceuticals
        7.2.1 Regeneron Pharmaceuticals Company Details
        7.2.2 Regeneron Pharmaceuticals Business Overview
        7.2.3 Regeneron Pharmaceuticals Nasal Polyps Treatment Introduction
        7.2.4 Regeneron Pharmaceuticals Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.2.5 Regeneron Pharmaceuticals Recent Development
    7.3 Merck
        7.3.1 Merck Company Details
        7.3.2 Merck Business Overview
        7.3.3 Merck Nasal Polyps Treatment Introduction
        7.3.4 Merck Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.3.5 Merck Recent Development
    7.4 Pfizer
        7.4.1 Pfizer Company Details
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Nasal Polyps Treatment Introduction
        7.4.4 Pfizer Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.4.5 Pfizer Recent Development
    7.5 F. Hoffmann La-Roche
        7.5.1 F. Hoffmann La-Roche Company Details
        7.5.2 F. Hoffmann La-Roche Business Overview
        7.5.3 F. Hoffmann La-Roche Nasal Polyps Treatment Introduction
        7.5.4 F. Hoffmann La-Roche Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.5.5 F. Hoffmann La-Roche Recent Development
    7.6 Intersect ENT
        7.6.1 Intersect ENT Company Details
        7.6.2 Intersect ENT Business Overview
        7.6.3 Intersect ENT Nasal Polyps Treatment Introduction
        7.6.4 Intersect ENT Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.6.5 Intersect ENT Recent Development
    7.7 GlaxoSmithKline
        7.7.1 GlaxoSmithKline Company Details
        7.7.2 GlaxoSmithKline Business Overview
        7.7.3 GlaxoSmithKline Nasal Polyps Treatment Introduction
        7.7.4 GlaxoSmithKline Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.7.5 GlaxoSmithKline Recent Development
    7.8 Sanofi
        7.8.1 Sanofi Company Details
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Nasal Polyps Treatment Introduction
        7.8.4 Sanofi Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.8.5 Sanofi Recent Development
    7.9 Novartis
        7.9.1 Novartis Company Details
        7.9.2 Novartis Business Overview
        7.9.3 Novartis Nasal Polyps Treatment Introduction
        7.9.4 Novartis Revenue in Nasal Polyps Treatment Business (2017-2022)
        7.9.5 Novartis Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Nasal Polyps Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Nasal Polyps Treatment Market Trends
    Table 3. Nasal Polyps Treatment Market Drivers
    Table 4. Nasal Polyps Treatment Market Challenges
    Table 5. Nasal Polyps Treatment Market Restraints
    Table 6. Global Nasal Polyps Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Nasal Polyps Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Nasal Polyps Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Nasal Polyps Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Nasal Polyps Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Nasal Polyps Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Nasal Polyps Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Nasal Polyps Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nasal Polyps Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Polyps Treatment as of 2021)
    Table 15. Top Players of Nasal Polyps Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Nasal Polyps Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Nasal Polyps Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Nasal Polyps Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Nasal Polyps Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Nasal Polyps Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Nasal Polyps Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Nasal Polyps Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Nasal Polyps Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Nasal Polyps Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Nasal Polyps Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Nasal Polyps Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Nasal Polyps Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. OptiNose US Company Details
    Table 31. OptiNose US Business Overview
    Table 32. OptiNose US Nasal Polyps Treatment Product
    Table 33. OptiNose US Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 34. OptiNose US Recent Development
    Table 35. Regeneron Pharmaceuticals Company Details
    Table 36. Regeneron Pharmaceuticals Business Overview
    Table 37. Regeneron Pharmaceuticals Nasal Polyps Treatment Product
    Table 38. Regeneron Pharmaceuticals Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 39. Regeneron Pharmaceuticals Recent Development
    Table 40. Merck Company Details
    Table 41. Merck Business Overview
    Table 42. Merck Nasal Polyps Treatment Product
    Table 43. Merck Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 44. Merck Recent Development
    Table 45. Pfizer Company Details
    Table 46. Pfizer Business Overview
    Table 47. Pfizer Nasal Polyps Treatment Product
    Table 48. Pfizer Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 49. Pfizer Recent Development
    Table 50. F. Hoffmann La-Roche Company Details
    Table 51. F. Hoffmann La-Roche Business Overview
    Table 52. F. Hoffmann La-Roche Nasal Polyps Treatment Product
    Table 53. F. Hoffmann La-Roche Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 54. F. Hoffmann La-Roche Recent Development
    Table 55. Intersect ENT Company Details
    Table 56. Intersect ENT Business Overview
    Table 57. Intersect ENT Nasal Polyps Treatment Product
    Table 58. Intersect ENT Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 59. Intersect ENT Recent Development
    Table 60. GlaxoSmithKline Company Details
    Table 61. GlaxoSmithKline Business Overview
    Table 62. GlaxoSmithKline Nasal Polyps Treatment Product
    Table 63. GlaxoSmithKline Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 64. GlaxoSmithKline Recent Development
    Table 65. Sanofi Company Details
    Table 66. Sanofi Business Overview
    Table 67. Sanofi Nasal Polyps Treatment Product
    Table 68. Sanofi Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 69. Sanofi Recent Development
    Table 70. Novartis Company Details
    Table 71. Novartis Business Overview
    Table 72. Novartis Nasal Polyps Treatment Product
    Table 73. Novartis Revenue in Nasal Polyps Treatment Business (2017-2022) & (US$ Million)
    Table 74. Novartis Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nasal Polyps Treatment Product Picture
    Figure 2. Global Nasal Polyps Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Nasal Polyps Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Nasal Polyps Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Nasal Polyps Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Nasal Polyps Treatment Market Share in Global 2017-2028
    Figure 7. Nasal Polyps Treatment Report Years Considered
    Figure 8. Product Picture of Pharmacological Therapies
    Figure 9. Product Picture of Surgeries
    Figure 10. Global Nasal Polyps Treatment Market Share by Type in 2022 & 2028
    Figure 11. Global Nasal Polyps Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Nasal Polyps Treatment Market Share by Type (2017-2028)
    Figure 13. United States Nasal Polyps Treatment Market Share by Type in 2022 & 2028
    Figure 14. United States Nasal Polyps Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Nasal Polyps Treatment Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Ambulatory Surgical Centers
    Figure 18. Product Picture of Specialty Clinics
    Figure 19. Global Nasal Polyps Treatment Market Share by Application in 2022 & 2028
    Figure 20. Global Nasal Polyps Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Nasal Polyps Treatment Market Share by Application (2017-2028)
    Figure 22. United States Nasal Polyps Treatment Market Share by Application in 2022 & 2028
    Figure 23. United States Nasal Polyps Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Nasal Polyps Treatment Market Share by Application (2017-2028)
    Figure 25. North America Nasal Polyps Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Nasal Polyps Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Nasal Polyps Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Nasal Polyps Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Nasal Polyps Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Nasal Polyps Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. OptiNose US Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 54. Regeneron Pharmaceuticals Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 55. Merck Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 57. F. Hoffmann La-Roche Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 58. Intersect ENT Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 60. Sanofi Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Nasal Polyps Treatment Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
OptiNose US
Regeneron Pharmaceuticals
Merck
Pfizer
F. Hoffmann La-Roche
Intersect ENT
GlaxoSmithKline
Sanofi
Novartis
Frequently Asked Questions
Nasal Polyps Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nasal Polyps Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nasal Polyps Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Guita Tuner

Guita Tuner market is segmented by region (country), players, by Type and by Application. Players ... Read More